These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 817594)
21. Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients. Zhang H; Yang Q; Liao K; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Chu Y; Chen S; Cao B; Su J; Duan Q; Zhang S; Shao H; Kong H; Gui B; Hu Z; Badal R; Xu Y BMC Infect Dis; 2017 Dec; 17(1):776. PubMed ID: 29254478 [TBL] [Abstract][Full Text] [Related]
22. [Drug sensitivity and beta-lactamase producibility of various types of bacteria clinically isolated during the period from December 1999 to February 2000]. Hashimoto K; Kinosita C; Yoshinaga H; Sonda Y; Itoyama T; Oyamada K; Kajimura K; Kondou M; Sagawa K; Ouno T; Kawamoto K; Souda K; Hara K; Kakihara M; Tanaka T; Ryutou M; Shichiji A; Nakashima K; Ishibashi K; Tabira R; Yamamoto S; Nishida M; Tsutsumi Y Jpn J Antibiot; 2002 Sep; 55 Suppl A():86-94. PubMed ID: 12599532 [TBL] [Abstract][Full Text] [Related]
23. Correlation of beta-lactamase production and resistance to beta-lactam antibiotics in Enterobacteriaceae. Cullmann W; Flensberg T; Opferkuch W; Stieglitz M; Wiedemann B Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Sep; 252(4):480-9. PubMed ID: 6758422 [TBL] [Abstract][Full Text] [Related]
24. Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012). Sader HS; Farrell DJ; Flamm RK; Jones RN J Infect; 2014 Sep; 69(3):266-77. PubMed ID: 24780763 [TBL] [Abstract][Full Text] [Related]
25. Synergism of PS-5 with penicillins and cephalosporins in antimicrobial activity against beta-lactam-resistant gram-negative microorganisms. Sakamoto M; Ishikura T; Fukagawa Y J Antibiot (Tokyo); 1984 Nov; 37(11):1414-22. PubMed ID: 6334679 [TBL] [Abstract][Full Text] [Related]
26. Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity. Neu HC; Fu KP Antimicrob Agents Chemother; 1978 Apr; 13(4):657-64. PubMed ID: 248268 [TBL] [Abstract][Full Text] [Related]
27. [Beta-lactamase activity of bacteria of the genus Proteus]. Shvidenko IG Antibiotiki; 1978 Mar; 23(3):223-7. PubMed ID: 246373 [TBL] [Abstract][Full Text] [Related]
28. Combinations of clavulanic acid and other beta-lactam antibiotics against strains of Pseudomonas aeruginosa, Serratia marcescens and other bacteria. Rogers DT; Russell AD J Appl Bacteriol; 1980 Aug; 49(1):111-8. PubMed ID: 6776086 [No Abstract] [Full Text] [Related]
29. [Purification of beta-lactamases by affinity chromatography]. Le Goffic F; Andrillon-Spiegel J; Letarte R Biochimie; 1975; 57(1):29-34. PubMed ID: 1096966 [TBL] [Abstract][Full Text] [Related]
30. [Antibacterial activities of monobactams against fresh clinical isolates]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297 [TBL] [Abstract][Full Text] [Related]
31. In vitro activity and beta-lactamase stability of BL-S786 compared with those of other cephalosporins. Aswapokee N; Aswapokee P; Fu KP; Neu HC Antimicrob Agents Chemother; 1978 Jul; 14(1):1-5. PubMed ID: 686701 [TBL] [Abstract][Full Text] [Related]
32. Occurrence of chloramphenicol-acetylating enzymes in various gram-negative bacilli. Okamoto S; Suzuki Y; Mise K; Nakaya R J Bacteriol; 1967 Nov; 94(5):1616-22. PubMed ID: 4964485 [TBL] [Abstract][Full Text] [Related]
33. Beta lactamase resistance of newer cephalosporins and antimicrobial effectiveness against gram-negative bacilli. Farrar WE; O'Dell NM Infection; 1977; 5(4):224-7. PubMed ID: 413793 [TBL] [Abstract][Full Text] [Related]
34. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon. Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589 [TBL] [Abstract][Full Text] [Related]
35. beta-Lactamase stability of some cephalosporins. Coppi G Ital J Biochem; 1984; 33(4):280A-285A. PubMed ID: 6439674 [No Abstract] [Full Text] [Related]
37. Mechanism of synergistic effects of beta-lactam antibiotic combinations on gram-negative bacilli. Farrar WE; Newsome JK Antimicrob Agents Chemother; 1973 Aug; 4(2):109-14. PubMed ID: 4598215 [TBL] [Abstract][Full Text] [Related]
38. [Antimicrobial susceptibility and beta-lactamase productivity of recent clinical isolates during the period between December 1999 and February 2000]. Notake S; Nakamura Y; Yanagisawa H; Haketa M; Ide K; Nagai K; Kakegawa J; Shiozawa J; Kobayashi S; Shimazaki Y; Naitoh M; Toda K; Fujiki K; Okimura Y; Okabe T Jpn J Antibiot; 2002 Sep; 55 Suppl A():111-8. PubMed ID: 12599534 [TBL] [Abstract][Full Text] [Related]
39. Cefaclor: in vitro spectrum of activity and beta-lactamase stability. Neu HC; Fu KP Antimicrob Agents Chemother; 1978 Apr; 13(4):584-8. PubMed ID: 666290 [TBL] [Abstract][Full Text] [Related]
40. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China. Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]